secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0000950170-23-021303
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences Q1 revenue $1.5M (down 53% YoY) but gross profit improves $922k
--------------------------------------------------------------------------------

- Total revenues $1.5M vs $3.2M; prior year included $1.8M in discontinued products.
- Loss from operations improved to $4.0M from $4.6M; operating expenses fell 29% to $5.6M.
- Cost of revenues down to $825k from $3.5M, driving $922k gross profit improvement.
- Private placement financing impact on net loss still under review; Q1 10-Q to be filed next week.
- GoodWheat pasta named 'Best New Product' by Retail Dietitians Business Alliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/0000950170-23-021303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023021303/rkda-20230511.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-021303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer